EquityZen Growth Technology Fund LLC - Series 1848
Raised
$247K
Investors
9
Min Invest
$10,006
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1848 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett. The fund raised $247K from 9 investors with a $10K minimum investment, relying on Rule 506(b) and 3(c)(1) exemptions. This is part of EquityZen's platform of 1,889 related entities offering pre-IPO exposure through serialized SPVs.
This pre-IPO fund follows the standard EquityZen model of low-minimum ($10K) 506(b) offerings targeting retail-accessible secondary market exposure. The raise size and investor count are consistent with the platform's serialized single-company SPV structure, allowing fractional access to private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Philip Haslett
Executive Officer, Director · New York, NY
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
